Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population

Human Immunology

Volumn 70, Issue 1, 2009, Pages 45-48

  Douik, Hayet ^a,b   Chaaben, Arij Ben ^a,b   Romdhane, Neila Attia ^c   Ben Romdhane, Habiba ^d   Mamoghli, Tesnim ^b   Fortier, Catherine ^a   Boukouaci, Wahid ^a   Harzallah, Latifa ^b   Ghanem, Abderraouf ^b   Gritli, Said ^b   Makni, Mohamed ^e   Charron, Dominique ^a   Krishnamoorthy, Rajagopal ^f   Guemira, Fethi ^b   Tamouza, Ryad ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b SALAH AZAIEZ INSTITUTE   (Tunisia)

^c CHARLES NICOLLE HOSPITAL   (Tunisia)

^d Department of Preventive Medicine   (Tunisia)

^e FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^f HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

MICA gene polymorphism; Nasopharyngeal cancer; Tunisia

Indexed keywords

AMINO ACID; HLA A ANTIGEN; METHIONINE; VALINE;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CANCER RESISTANCE; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CELL FUNCTION; CHILD; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN RELATED A GENE; MALE; NASOPHARYNX CANCER; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUNISIA;

ADULT; AGED; AMINO ACID SUBSTITUTION; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; POLYMORPHISM, GENETIC; RISK; TUNISIA;

EID: 58149473462     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.10.008     Document Type: Article

References (30)

1. Parkin D.M., and Muir C.S. Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ 120 (1992) 45-173
2. Bouchardy C., Parkin D.M., Wanner P., and Khlat M. Cancer mortality among North African migrants in France. Int J Epidemiol 25 (1996) 5-13
3. Cammoun M., Hoerner V., and Mourali N. Tumors of the nasopharynx in Tunisia. An anatomic and clinical study based on 143 cases. Cancer 33 (1974) 184-192
4. Burgos J.S. Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis. Med Oncol 22 (2005) 113-121
5. Chan A.T., Teo P.M., and Johnson P.J. Nasopharyngeal carcinoma. Ann Oncol 13 (2002) 1007-1015
6. Feng B.J., Jalbout M., Ayoub W.B., Khyatti M., Dahmoul S., Ayad M., et al. Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries. Int J Cancer 21 (2007) 1550-1555
7. Tao Q., and Chan A.T. Nasopharyngeal carcinoma: Molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 9 (2007) 1-24
8. Lo K.W., and Huang D.P. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 12 (2002) 451-462
9. Goldsmith D.B., West T.M., and Morton R. HLA associations with nasopharyngeal carcinoma in Southern Chinese: A meta-analysis. Clin Otolaryngol Allied Sci 27 (2002) 61-67
10. Gastpar H., Wilmes E., and Wolf H. Epidemiologic, etiologic and immunologic aspects of nasopharyngeal carcinoma [NPC]. J Med 12 (1981) 257-284
11. Bahram S., Bresnahan M., Geraghty D.E., and Spies T.A. second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 1 (1994) 6259-6263
12. Bahram S. MIC genes: From genetics to biology. Adv Immunol 76 (2000) 1-60
13. Eagle R.A., and Trowsdale J. Promiscuity and the single receptor: NKG2D. Nat Rev Immunol 7 (2007) 737-744
14. Schrambach S., Ardizzone M., Leymarie V., Sibilia J., and Bahram S. In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer. PLoS ONE 2 (2007) e518
15. IMGT/HLA Sequence Database. Available at: http://www.ebi.ac.uk/imgt/hla/.
16. Tian W., Zeng X.M., Li L.X., Jin H.K., Luo Q.Z., Wang F., et al. Gender-specific associations between MICA-STR and nasopharyngeal carcinoma in a southern Chinese Han population. Immunogenetics 58 (2006) 113-121
17. Steinle A., Li P., Morris D.L., Groh V., Lanier L.L., Strong R.K., et al. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 53 (2001) 279-287
18. Amroun H., Djoudi H., Busson M., Allat R., El Sherbini S.M., Sloma I., et al. Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism. Hum Immunol 66 (2005) 1057-1061
19. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. TNM Classification of Malignant Tumors, fifth edition (1997). Cancer 80 (1997) 1803-1804
20. IARC (International Agency for Research on Cancer). Available at: www.gep.iarc.fr/npc/fr/epidemnpc.html. (Carcinome du Nasopharynx 2004). Accessed April 2008.
21. Mokni-Baizig N., Ayed K., Ayed F.B., Ayed S., Sassi F., Ladgham A., et al. Association between HLA-A/-B antigens and -DRB1 alleles and nasopharyngeal carcinoma in Tunisia. Oncology 61 (2001) 55-58
22. Hassen E., Farhat K., Gabbouj S., Jalbout M., Bouaouina N., and Chouchane L. TAP1 gene polymorphisms and nasopharyngeal carcinoma risk in a Tunisian population. Cancer Genet Cytogenet 175 (2007) 41-46
23. Jalbout M., Bouaouina N., Gargouri J., Corbex M., Ben Ahmed S., and Chouchane L. Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma. Cancer Lett 193 (2003) 75-81
24. Li X., Ghandri N., Piancatelli D., Adams S., Chen D., Robbins F.M., et al. Associations between HLA class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians. J Transl Med 5 (2007) 22-35
25. Gao X., Single R.M., Karacki P., Marti D., O'Brien S.J., and Carrington M. Diversity of MICA and linkage disequilibrium with HLA-B in two North American populations. Hum Immunol 67 (2006) 152-158
26. Piancatelli D., Del Beato T., Oumhani K., El Aouad R., and Adorno D. MICA polymorphism in a population from north Morocco, Metalsa Berbers, using sequence-based typing. Hum Immunol 66 (2005) 931-936
27. Kaiser B.K., Yim D., Chow I.T., Gonzalez S., Dai Z., Mann H.H., et al. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature 447 (2007) 482-486
28. Arreygue-Garcia N.A., Daneri-Navarro A., del Toro-Arreola A., Cid-Arregui A., Gonzalez-Ramella O., Jave-Suarez L.F., et al. Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions. BMC Cancer 8 (2008) 16-26
29. Märten A., von Lilienfeld-Toal M., Büchler M.W., and Schmidt J. Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing gammadelta T cell cytotoxicity. Int J Cancer 119 (2006) 2359-2365
30. Rebmann V., Schütt P., Brandhorst D., Opalka B., Moritz T., Nowrousian M.R., et al. Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients. Clin Immunol 123 (2007) 114-120